Invest in

Fighting Fat

55.1%
4.7%
2.4%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
55.1%
4.7%
2.4%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
42.5% Weight Loss Drugs --
42.5% Arena Pharmaceuticals Inc. ARNA --
30.0% Weight Management 134.0%
13.6% NutriSystem Inc NTRI 92.6%
7.7% Weight Watchers International Inc WTW 320.1%
5.7% MEDIFAST INC MED 55.9%
1.9% Nu Skin Enterprises Inc. (A) NUS 2.4%
0.5% USANA Health Sciences Inc. USNA 15.2%
0.3% GNC Holdings Inc. Class A GNC 52.1%
0.2% Vitamin Shoppe Inc VSI 78.8%
27.5% Diabetes Care 11.7%
8.2% Sanofi SNY 26.5%
8.1% Merck & Company Inc. (new) MRK 0.4%
7.7% Novo Nordisk A/S NVO 1.3%
1.3% Astrazeneca Plc ADR AZN 10.3%
1.2% Integer Holdings Corporation ITGR 97.0%
1.0% Alkermes plc ALKS 11.8%

Quotes delayed 15 mins. Currently Aug 23, 2017 2:16:49 AM. Fields are marked with -- when data is unavailable.